Literature DB >> 20425259

Lipidomics as a tool for the study of lipoprotein metabolism.

Anatol Kontush1, M John Chapman.   

Abstract

Although technologies for lipidomic and proteomic investigations have developed very recently, lipidomic and proteomic studies of plasma lipoproteins have already provided several impressive examples of detailed characterization of distinct metabolic pathways potentially involved in lipoprotein metabolism in both health and disease states (obesity, insulin resistance, fatty liver disease) as well as under lifestyle and dietary modification (fish consumption, carbohydrates, probiotics) and lipid-modifying treatments (statins, low-density lipoprotein apheresis). Available lipidomic methodologies have facilitated detailed characterization of lipid classes and molecular species present in plasma as well as in lipoprotein fractions. Together with emerging proteomic techniques, lipidomics of plasma lipoproteins will soon provide molecular details of lipoprotein composition, which will ultimately be translated into integrated knowledge of the structure, metabolism, and function of lipoproteins in health and disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425259     DOI: 10.1007/s11883-010-0100-0

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  40 in total

1.  Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles.

Authors:  B Asztalos; W Zhang; P S Roheim; L Wong
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

2.  Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease.

Authors:  V D F de Mello; M Lankinen; U Schwab; M Kolehmainen; S Lehto; T Seppänen-Laakso; M Oresic; L Pulkkinen; M Uusitupa; A T Erkkilä
Journal:  Diabetologia       Date:  2009-08-11       Impact factor: 10.122

3.  Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations.

Authors:  A Kotronen; V R Velagapudi; L Yetukuri; J Westerbacka; R Bergholm; K Ekroos; J Makkonen; M-R Taskinen; M Oresic; H Yki-Järvinen
Journal:  Diabetologia       Date:  2009-02-13       Impact factor: 10.122

4.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

Authors:  Boris Hansel; Philippe Giral; Estelle Nobecourt; Sandrine Chantepie; Eric Bruckert; M John Chapman; Anatol Kontush
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

Review 5.  Spotlight on HDL-raising therapies: insights from the torcetrapib trials.

Authors:  Anatol Kontush; Maryse Guérin; M John Chapman
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-22

6.  Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.

Authors:  Riina-A Kekkonen; Marko Sysi-Aho; Tuulikki Seppanen-Laakso; Ilkka Julkunen; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

7.  Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction.

Authors:  P V Subbaiah; M Liu
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

8.  Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins.

Authors:  Sandrin C Bergheanu; Theo Reijmers; Aeilko H Zwinderman; Ivana Bobeldijk; Raymond Ramaker; An-Ho Liem; Jan van der Greef; Thomas Hankemeier; J Wouter Jukema
Journal:  Curr Med Res Opin       Date:  2008-07-24       Impact factor: 2.580

9.  A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.

Authors:  Reijo Laaksonen; Mikko Katajamaa; Hannu Päivä; Marko Sysi-Aho; Lilli Saarinen; Päivi Junni; Dieter Lütjohann; Joél Smet; Rudy Van Coster; Tuulikki Seppänen-Laakso; Terho Lehtimäki; Juhani Soini; Matej Oresic
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

Authors:  Ida Chiara Guerrera; Giuseppe Astarita; Jean-Philippe Jais; Dorota Sands; Anna Nowakowska; Julien Colas; Isabelle Sermet-Gaudelus; Martin Schuerenberg; Daniele Piomelli; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

View more
  18 in total

1.  Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation.

Authors:  Colin S McCoin; Brian D Piccolo; Trina A Knotts; Dietrich Matern; Jerry Vockley; Melanie B Gillingham; Sean H Adams
Journal:  J Inherit Metab Dis       Date:  2016-02-23       Impact factor: 4.982

Review 2.  Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses.

Authors:  Xianlin Han; Kui Yang; Richard W Gross
Journal:  Mass Spectrom Rev       Date:  2011-07-13       Impact factor: 10.946

3.  Changes in relative and absolute concentrations of plasma phospholipid fatty acids observed in a randomized trial of Omega-3 fatty acids supplementation in Uganda.

Authors:  Xiaoling Song; Pho Diep; Jeannette M Schenk; Corey Casper; Jackson Orem; Zeina Makhoul; Johanna W Lampe; Marian L Neuhouser
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-09-30       Impact factor: 4.006

Review 4.  Functional genomics applied to cardiovascular medicine.

Authors:  Thomas P Cappola; Kenneth B Margulies
Journal:  Circulation       Date:  2011-07-05       Impact factor: 29.690

5.  Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.

Authors:  Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Marcio Almeida; Vincent Diego; Juan Manuel Peralta; Christopher K Barlow; Claire Bellis; Thomas D Dyer; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; Harald H H Göring; Joanne E Curran; John Blangero
Journal:  J Lipid Res       Date:  2014-03-13       Impact factor: 5.922

Review 6.  New technologies personalize diagnostics and therapeutics.

Authors:  Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

Review 7.  Unraveling the complexities of the HDL lipidome.

Authors:  Anatol Kontush; Marie Lhomme; M John Chapman
Journal:  J Lipid Res       Date:  2013-03-30       Impact factor: 5.922

8.  Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Authors:  Andrew N Hoofnagle; Mingyuan Wu; Albina K Gosmanova; Jessica O Becker; Ellen M Wijsman; John D Brunzell; Steven E Kahn; Robert H Knopp; Timothy J Lyons; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-16       Impact factor: 8.311

9.  Variability in associations of phosphatidylcholine molecular species with metabolic syndrome in Mexican-American families.

Authors:  Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Christopher K Barlow; Jeremy B Jowett; Claire Bellis; Thomas D Dyer; Matthew P Johnson; David L Rainwater; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; John Blangero; Joanne E Curran
Journal:  Lipids       Date:  2013-03-14       Impact factor: 1.880

10.  Dietary intake of palmitate and oleate has broad impact on systemic and tissue lipid profiles in humans.

Authors:  C Lawrence Kien; Janice Y Bunn; Robert Stevens; James Bain; Olga Ikayeva; Karen Crain; Timothy R Koves; Deborah M Muoio
Journal:  Am J Clin Nutr       Date:  2014-01-15       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.